CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos
In 2016, the EGF-Predictor Phase IV Clinical Trial Opening Workshop was held in Cienfuegos, sponsored by the Center for Molecular Immunology of Havana which coexist with other clinical trials. The overall objective of the study is to evaluate the safety and efficacy of the CIMAVAX-EGF therapeutic va...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
Universidad de las Ciencias Médicas de Cienfuegos
2017-04-01
|
| Series: | Finlay : Revista de Enfermedades no Transmisibles |
| Subjects: | |
| Online Access: | http://revfinlay.sld.cu/index.php/finlay/article/view/531 |